DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Baci-rx is a drug marketed by X Gen Pharms and is included in one NDA.
The generic ingredient in BACI-RX is bacitracin. There are twenty-seven drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the bacitracin profile page.
A generic version of BACI-RX was approved as bacitracin by PADAGIS US on December 31st, 1969.
Anatomical Therapeutic Chemical (ATC) Classes for BACI-RX
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|X Gen Pharms||BACI-RX||bacitracin||POWDER;FOR RX COMPOUNDING||061580-001||Approved Prior to Jan 1, 1982||DISCN||No||No||⤷ Free Forever Trial||⤷ Free Forever Trial||⤷ Free Forever Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|